Chugai Pursues Alecensa Patent Infringement Charges In India

Roche affiliate Chugai has moved court in India seeking to restrain Natco and MSN Laboratories over alleged infringement of its patent concerning Alecensa. The Indian firms, however, contend their actions fall under the ambit of the country’s “Bolar exemption” provision.

patent infringment
Chugai pursues legal action in India over alectinib patent • Source: Alamy

More from India

More from Focus On Asia